Generic Firms Warned Of First-To-File Risk: Willful Infringement Cases Rising
Executive Summary
The pressure on generic companies to be first-to-file in patent challenges will lead to a "boom" in willful infringement cases against generics makers, an industry attorney maintains
You may also be interested in...
ANDA filing not “willful infringement”
The filing of an ANDA cannot constitute "willful infringement" under Waxman/ Hatch, a federal appeals court rules July 27. Federal Circuit reverses a Chicago judge's decision ordering Apotex to pay GlaxoSmithKline attorneys' fees in a Ceftin patent dispute (1"The Pink Sheet" June 2, 2003, p. 29). Apotex was enjoined from marketing its generic until the patents expired in July 2003...
ANDA filing not “willful infringement”
The filing of an ANDA cannot constitute "willful infringement" under Waxman/ Hatch, a federal appeals court rules July 27. Federal Circuit reverses a Chicago judge's decision ordering Apotex to pay GlaxoSmithKline attorneys' fees in a Ceftin patent dispute (1"The Pink Sheet" June 2, 2003, p. 29). Apotex was enjoined from marketing its generic until the patents expired in July 2003...
Zyprexa Willful Infringement Claim Dismissal Could Speed Ivax Launch
Ivax said it is more likely to launch its generic of the antipsychotic Zyprexa ahead of an appellate court decision now that Lilly has agreed to dismiss a willful infringement claim prior to trial